Cadila Healthcare has informed that it has enclosed a Press Release dated July 6, 2020 titled ‘Zydus receives approval from COFERIS, Mexico to study Desidustat in the management of COVID-19’. The contents of the Press Release give full details. Bring the aforesaid news to the notice of the members of the exchange and investors’ at large.
The above information is a part of company’s filings submitted to BSE.